{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Brown CA"],"pubmed_abstract":["<h4>Importance</h4>Even within individuals who are amyloid positive, clinical symptoms can be impacted by Alzheimer pathology, other pathologic proteins, and cognitive reserve or resilience. Understanding how each of these factors contributes to a patient's clinical presentation is crucial for prognosis and treatment decisions in the era of disease-modifying therapies.<h4>Objective</h4>To evaluate tau-clinical mismatch as a means to identify those more likely to harbor copathology and/or exhibit resilience to Alzheimer pathology.<h4>Design, setting, and participants</h4>This was a longitudinal, observational cohort study conducted from 2004 to 2024. The setting included multiple academic medical centers in the US participating in the Alzheimer's Disease Neuroimaging Initiative (ADNI) or Pe"],"journal":["JAMA neurology"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12706664"],"repository":["biostudies-literature"],"pubmed_title":["Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch."],"pmcid":["PMC12706664"],"pubmed_authors":["Fox NC","Lacy K","Shen L","Crawford K","Bernard M","Di Benedetto J","Kaddurah-Daouk R","LoPresti B","Hoang I","Wan Y","Wolk DA","Saito N","Strong J","Senjem M","Miller MJ","Brown CA","Carrillo M","Karlawish J","Thal L","Jin C","Villemagne V","DeCarli C","Okonkwo O","Gunter J","Sadeghpour N","Silverberg N","Parkins S","Lee VMY","Masliah E","Salazar J","Knaack A","Yushkevich PA","Montine T","Shaffer E","Taylor-Reinwald L","Pizzola J","Sachdev P","Fidell A","Frank R","Reyes C","Jenkins C","Reyes D","Nudelman K","Matoush L","Moore-Weiss J","Walter S","Grill J","Tosun D","Gonzalez H","Fletcher E","Lee EB","Detre JA","Robison J","Molchan S","Cairns NJ","Schwarz C","Malone I","Ayo O","Buckholtz N","Neu S","Toga AW","Khachaturian Z","Thomas L","Masterman D","Cabrera Y","Conti C","Nir TM","Risacher SL","Felmlee J","Boatwright V","Aisen P","Clanton T","Mahboubi P","Foroud TM","Webb C","Weiner M","Snyder PJ","Guzman V","Harkins K","Raman R","Glittenberg M","Talavera S","Zimmerman C","Craft H","McGrew E","Jo T","Forghanian-Arani A","Apostolova LG","McMillan CT","Truran Sacrey D","Beckett L","Hedberg C","Jack CR","Borowski B","Fockler J","Kwang W","Landau S","Ajayi A","Koeppe RA","Ashford M","Weisensel T","Rossi Chen S","Green RC","Perrin R","Amaza H","Seng Thao M","Kachaturian Z","Barnes L","Ho C","Xie L","Largent E","Nasrallah IM","Hergesheimer L","Potter Z","Adem Hussen K","Rabinovici G","Potter W","Cousins KAQ","Chen-Plotkin A","Korecka M","Bernhardt H","Nho K","Harvey D","Ward C","Diaz A","Wisse LEM","Franklin E","Ryan L","Das S","Mundada NS","Lyu X","Choe M","Drake E","Kormos A","Reid R","Alzheimer’s Disease Neuroimaging Initiative","Adegoke O","Nosheny R","Rivera-Mindt M","Mechanic-Hamilton D","Ogwang S","Rafii M","Morris J","Erickson C","Das SR","Brylska M","Flenniken D","Jackson J","Jagust W","Saykin AJ","Hsiao JK","Magana F","Jahanshad N","Trojanowki JQ","Donohue M","Faber K","Jimenez G","Thompson P","Smith S","Thomopoulos SI","Shaw LM","Kubo Germano K","Vemuri P","Kantarci K","Petersen R"],"additional_accession":[]},"is_claimable":false,"name":"Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch.","description":"<h4>Importance</h4>Even within individuals who are amyloid positive, clinical symptoms can be impacted by Alzheimer pathology, other pathologic proteins, and cognitive reserve or resilience. Understanding how each of these factors contributes to a patient's clinical presentation is crucial for prognosis and treatment decisions in the era of disease-modifying therapies.<h4>Objective</h4>To evaluate tau-clinical mismatch as a means to identify those more likely to harbor copathology and/or exhibit resilience to Alzheimer pathology.<h4>Design, setting, and participants</h4>This was a longitudinal, observational cohort study conducted from 2004 to 2024. The setting included multiple academic medical centers in the US participating in the Alzheimer's Disease Neuroimaging Initiative (ADNI) or Pe","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-06-07T05:21:34.037Z","creation":"2026-06-07T03:07:12.072Z"},"accession":"S-EPMC12706664","cross_references":{"pubmed":["41396614"],"doi":["10.1001/jamaneurol.2025.4974"]}}